Filter
423
Filtered Results: 423
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
59
New Publications
132
Language
Document type
No document type
222
Guidelines
79
Studies & Reports
53
Strategic & Response Plan
26
Manuals
22
Fact sheets
8
Training Material
6
Situation Updates
3
Resource Platforms
1
Infographics
1
Online Courses
1
Videos
1
Countries / Regions
Kenya
26
South Africa
16
India
16
Ghana
15
Nigeria
15
Western and Central Europe
14
Uganda
14
Eastern Europe
11
Ethiopia
11
Nepal
10
Rwanda
10
Namibia
10
Global
9
Sierra Leone
8
Malawi
8
Tanzania
8
Zambia
8
Latin America and the Carribbean
6
South–East Asia Region
6
Senegal
5
Philippines
5
Cambodia
5
Bangladesh
5
Botswana
5
Liberia
5
Africa
4
West and Central Africa
4
East and Southern Africa
4
Russia
4
Lesotho
3
Zimbabwe
3
Mozambique
3
Middle East and North Africa
3
Haiti
2
Asia
2
Congo, Democratic Republic of
2
Eastern Europe and Central Asia
2
Lebanon
2
Brazil
2
Sudan
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Ukraine
1
Benin
1
Gambia
1
Cameroon
1
Syria
1
Laos
1
Burkina Faso
1
Afghanistan
1
Morocco
1
Jordan
1
Western Pacific Region
1
Paraguay
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
217
Clinical Guidelines
55
Public Health
16
Women & Child Health
8
Pharmacy & Technologies
8
Capacity Building
6
Key Resources
6
Toolboxes
TB
51
Pharmacy
47
AMR
41
COVID-19
29
HIV
22
NTDs
20
Planetary Health
4
NCDs
4
Rapid Response
3
Caregiver
3
Refugee
2
Specific Hazards
1
Cholera
1
Ebola & Marburg
1
Malaria
1
Zika
1
Polio
1
Global Health Education
1
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
Report of a mission 20–24 April 2015
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
HIV Treatment
Policy Brief
July 2017
Accessed November 2017
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
2014-2020, Draft March 2014
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
